Community based integrated intervention for prevention and management of Chronic Obstructive Pulmonary Disease in Guangdong, China: cluster randomised.

Slides:



Advertisements
Similar presentations
Effect of high flow oxygen on mortality in chronic obstructive pulmonary disease patients in prehospital setting: randomized control trial (BMJ. 2010;341:c5462)
Advertisements

Definition of COPD COPD is a preventable and treatable disease with some significant extrapulmonary effects that may contribute to the severity in individual.
GARD Global Alliance against Chronic Respiratory Diseases WHO J Bousquet, R Dahl, N Khaltaev, HJ Bekedam.
GOLD MANAGEMENT PLAN FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Pulmonary Function Testing
BY DR.Khaled Helmy Chest Specialist Al Mahmora Chest Hospital Ministry of Health - Egypt COPD SCOPE ON.
Optimizing the Management of Chronic Obstructive Pulmonary Disease (COPD) Note to the Speaker: All bold underlined statements must be read aloud to the.
Academy Board Prep PCCM
UPLIFT Understanding Potential Long-term Impacts on Function with Tiotropium Adapted from Tashkin et al. NEJM 2008: 359: Please be advised that.
Health risks of smoking Principal fatal diseases caused by smoking are cancer, COPD and CVD In addition, smoking is an important cause of morbidity Risks.
CGHR.ORG Twitter: CGHR_org 21 st century hazards of smoking and benefits of cessation in the United States Jha P, Ramasundarahettige C, Landsman V, Thun.
Predicting & Preventing Postoperative Pulmonary Complication Wael A Batobara FRCPC Internal Med,Pulmonary & Critical care medicine ABIM Internal Med,Pulmonary.
4.6 Assessment of Evaluation and Treatment 2013 Analytic Lung Cancer.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence May–June 2013.
8 th ANNUAL CONGRESS OF TURKISH THORACIC SOCIETY April 27 – May 1, 2005 Antalya, TURKEY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN WORKERS OF FERROCHROME.
CEEH workshop February 2008 The importance of demographic changes Henrik Brønnum-Hansen University of Southern Denmark.
Dr. Danny Galdermans Dept Respiratory Medicine ZNA Middelheim Antwerp
Applied Epidemiology Epidemiology of Chronic Obstructive Pulmonary Disease (COPD) By Chris Callan 23 April 2008.
Chia-Fang Wu 1 Ming-Tsang Wu 1-2 Inn-Wen Chong 3 Kuen-Yuh Wu 4 Chi-Kung Ho 1 Chien-Hung Lee 5 Jhi-Jhu Huang 3 Chia-Tsuan Huang 2 Chung-Ying Lee 2 Trong-Neng.
©LTPHN 2008 Respiratory Diseases Name Speaker. ©LTPHN 2008 Respiratory Disease – Global Burden Very common worldwide Substantial preventable morbidity.
05/12/04 Lung Health StudySlide 1 of 6 Lung Health Study Heavy Smokers Experienced a Greater Benefit in the Reduction of the Decline Rate of their Pulmonary.
COPD MANAGEMENT FALLS SHORT AT RCRMC Jean Solomon, M.D.
Definition of COPD COPD is a preventable and treatable disease with some significant extrapulmonary effects that may contribute to the severity in individual.
BY….. Evelyn Kihunde, Linda A. Dufie, Richie Isom 1.
Review Session November 29, Questions Study Design - 1 Questionnaires were mailed to every 10 th person listed in city telephone directory. Each.
The Oxford Health Alliance The Oxford Health Alliance Community Interventions for Health (CIH) Sponsored by the PepsiCo Foundation.
© 2013 Global Initiative for Chronic Obstructive Lung Disease
St. Clair Health Care Commission Mobilizing for Action through Planning & Partnership Community Health Status Assessment.
Chronic Obstructive Pulmonary Disease
Habib GHEDIRA, MD, Prof. Medical Faculty of Tunis
Interpretation Normal Spirometry Obstructive pattern Restrictive pattern Mixed pattern Small airway obstruction Non-specific ventilatory pattern Probably.
 Smoking is the primary cause of avoidable death  Thousand of teens try cigarettes daily.  Smoking contributes to an astonishing number of diseases.
WMMC Symposium. Centers For Disease Control What Is Chronic Obstructive Pulmonary Disease (COPD)?  COPD is the name for a group of diseases that restrict.
Exposure of minority ethnic groups to second-hand smoke, in England Sarwat Shah Team: Kamran Siddiqi, Amanda Amos, Helen Tilbrook, Aziz Sheikh, Caroline.
GOLD Update 2011 Rabab A. El Wahsh, MD. Lecturer of Chest Diseases and Tuberculosis Minoufiya University REVISED 2011.
Focus Area 24 Respiratory Diseases Progress Review June 29, 2004.
My conflicts of interest during the last two years GSK has supported my participation in ERS congress 2010 Utrecht, September the 23th 2011.
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention National Center for Health Statistics Occupational exposure to.
COPD Diagnosis & Management Anil Ramineni Specialist Respiratory Physiotherapist Community Respiratory Team.
Long term effects of air pollution on health. Peter Burney. King’s College London.
COPD Local Burden. Population Prevalence of GOLD Stage I and Stage II & Doctor Diagnosed COPD in Manila, Philippines Source: BOLD Study, 2007;Dantes R.
COPD ) ) Chronic Obstructive Pulmonary Disease. Introduction n COPD is a preventable and treatable disease with some significant extrapulmonary effects.
Health Statistics and Informatics Non-communicable diseases A global overview.
1 Asthma in Children and Exposure to Environmental Tobacco Smoke in the Home Buddy R. Bates, MSPH Chronic Disease Epidemiology Unit Louisiana Office of.
CAPSTONE PROJECT. Setting the scene- why smoking cessation is important in the treatment of COPD.
Dr. Nadira Mehriban. INTRODUCTION Diabetic retinopathy (DR) is one of the major micro vascular complications of diabetes and most significant cause of.
LSU Journal Club Withdrawal of Inhaled Glucocorticoids and Exacerbations of COPD WISDOM study H. Magnussen MD, et al. Nisha Loganantharaj, PGY1 April 21,
Daniel B. Jamieson, Elizabeth C. Matsui, Andrew Belli1, Meredith C. McCormack, Eric Peng Simon Pierre-Louis, Jean Curtin-Brosnan, Patrick N. Breysse, Gregory.
COPD Local Burden The Philippines. COPD A Global Health Concern COPD a growing cause of morbidity & mortality worldwide 5 th leading cause of death (2002)
PREVALANCE OF POST-TUBERCULOSIS AIRFLOW OBSTRUCTION IN PATIENTS WHO HAVE COMPLETED PULMONARY TUBERCULOSIS TREATMENT AT TWO INFECTIOUS DISEASES HOSPITALS.
Management of stable chronic obstructive pulmonary disease (2) Seminar Training Primary Care Asthma + COPD D.Anan Esmail.
CHEST 2014; 145(4): 호흡기내과 R3 박세정. Cigarette smoking ㅡ the most important risk factor for COPD in the US. low value of FEV 1 : an independent predictor.
COPD SPUTUM PRODUCERS AND THE INFLUENCE ON ANTIBIOTIC RESISTANCE Sarah Thurston PhD student.
Reducing Tobacco Intake Lowers Risk of Lung Cancer in Heavy Smokers Slideset on: Godtfredsen NS, Prescott E, Osler M. Effect of smoking reduction on lung.
Date of download: 6/28/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Obstructive Lung Disease and Low Lung Function in.
Chest 2008;133; Juan P. de Torres, Victor Pinto-Plata, Ciro Casanova, Hanna Mullerova, Elizabeth Córdoba-Lanús, Mercedes Muros de Fuentes, Armando.
Roberto de Marco, Simone Accordini, Alessandro Marcon, Isa Cerveri Josep M. Anto, Thorarinn Gislason,Joachim Heinrich,Christer Janson, Deborah Jarvis,
COPD 2003.
External multicentric validation of a COPD detection questionnaire.
Chronic Obstructive Pulmonary Disease(COPD)
An effective COPD case finding strategy in Primary Care
Lynn Josephs, David Culliford, Matthew Johnson, Mike Thomas
2nd Eurasian Respiratory & Allergy Summit.
Blood eosinophil count and exacerbation risk in patients with COPD
Prof Dr Guy JOOS Dept Respiratory Medicine Ghent University Hospital
Interpretation Normal Spirometry Obstructive pattern
COPD Chronic Obstructive Lung Disease
D94- COPD: EPIDEMIOLOGY AND THERAPY
COPD Chronic Obstructive Lung Disease
Khai Hoan Tram, Jane O’Halloran, Rachel Presti, Jeffrey Atkinson
Presentation transcript:

Community based integrated intervention for prevention and management of Chronic Obstructive Pulmonary Disease in Guangdong, China: cluster randomised controlled trial Zhou Y et al BMJ 2010; 341 Moderator: Dr P R Deshmukh Presenter: Dr Himani

Introduction COPD has become a major public health problem worldwide Current interventions are carried out in hospital Little attention has been paid to community based integrated interventions for earlier stages of disease

Objective of study : To evaluate the effects of community based integrated intervention for early prevention and management of chronic obstructive pulmonary disease (COPD) in China Learning Objective: To learn about analysis of RCT

Methodology Study Area: Guangzhou city, China Study duration: September 2002 to May 2007 Study Population: All participants aged years Exclusion criteria- Diagnosis with active Tuberculosis, asthma or bronchiectasis, cystic fibrosis, interstitial lung disease, or pulmonary thromboembolic disease, malignant tumor, history of thoracotomy with pulmonary resection Study Design: Cluster Randomised Trial

Sample Size: N= 2(Z α +Z β ) 2 (SD) 2 * δ (µ1-µ2) 2 (µ1-µ2) = Mean difference = 20 SD= standard deviation = 80 δ = design effect = 2.2 δ= 1+(m-1)ρ, m=cluster size, ρ= intracluster correlation coefficient N= 1102

Flowchart for methodology

Components and timings of Integrated Intervention

Table1: Baseline characteristics within health care units Intervention CommunityControl community No. of units44 Total targeted population aged> 40 years Mean(SD) population aged> 40 years608(43)636(42) Mean(SD) annual income per unit17425(608)17031(190) Men1218(50)1269(50) Age ≥60994(41)1071(42) < 6 years’ education970(40)1043(41) Current smokers203(22)209(23) Aware of COPD40(20)37(18) Aware of hazards of smoking Not aware37(18)38(18) Know a little76(37)93(39) Know more90(44)90(43)

Table 2: Baseline Characteristics of participants randomly selected from 2 communities Intervention communityControl community No. Of participants436 Men211(48)188 (43) Age (years) Mean (SD)60.15 (11.31)60.38(11.53) <60205 (47)192(44) ≥ (53)244(56) Years of education <6187 (43)205 (47) (24)113(26) ≥ (33)118(27) BMI: Mean (SD)22.89(3.45)22.77 (3.66) < (9)42 (10) ≥ (91)394(90)

Table 2 cont… Intervention communityControl community Mean (SD)FEV12.03 (0.62)2.04 (0.63) Mean (SD)% predicted FEV (19.45)90.91 (20.69) Mean (SD)FVC2.59(0.72)2.56 (0.72) Mean (SD)% predicted FVC94.66(18.59)96.20 (18.74) FEV1/FVC ratio (%)78.27 (10.03)79.44 (9.88) Distribution of COPD & non- COPD Healthy population106 (24)92 (21) High risk for COPD282 (65)291 (67) Stage I COPD9 (2)10 (2) Stage II COPD24 (6) Stage III COPD or over15 (3)19 (4) Reversibility among COPD5 (10)7 (13) Previous diagnosis of respiratory disorders 76 (17)83 (19) Respiratory symptoms157 (36)153 (35)

Table 2 cont… Intervention communityControl community Occupation history of dust/ gases/ fumes 150 (34)249 (57) Respiratory infection during childhood 15 (3)20 (5) Smoking status at baseline survey Never smoker241 (55)235 (54) Smoking cessation77 (18)63 (14) Current smoker118 (27)138 (32) Smoking amounts (pack years) (21.39)14.31 (21.80) Exposed to environmental tobacco smoke 302 (70) 315 (73)

Table3: Difference between two communities in annual rate of decline in FEV1, FEV1/FVC Intervention communityControl CommunityAdjusted difference No.Mean (SE)No.Mean (SE)Mean (95% CI) P value Total population FEV1 (ml/year)42930 (3)43149 (3)19(3- 36)0.023 FEV1(predicted % per year) (0.2) (0.2)0.9 ( ) FEV1/FVC (0.1)4310.4(0.1)0.6 ( ) Participants without COPD FEV1(ml/year)38226 (3)37950(3)20 (3-37)0.025 FEV1(predicted % / year) (0.2) (0.2)1.1 (0.2-2)0.021 FEV1/FVC (0.1) (0.1)0.7 ( ) 0.019

Table 4: Awareness of health knowledge, change of risk factors, cumulative incidence rate, and case death rate between two communities after intervention InterventionControlAdjusted odds ratio p value Awareness of COPD Not aware78 (23)259 (78)Reference- Aware263 (77)72 (22)12.13 ( )<0.001 Awareness of smoking Hazard Not aware27 (8)57 (17)Reference- Know a little125 (37)125 (38)2.11 ( )0.005 Know more189 (55)149 (45)2.68 ( )<0.001 Outdoor air pollution Improved115 (27)83(19)1.73 ( )0.039 No change241 (56)247 (57)Reference- worsened76 (18)105 (24)0.74 ( )0.091 Working conditions Improved24 (6)14 (3)1.73 ( )0.113 No change407 (93)410 (94)Reference- Worsened5 (1)12 (3)0.42 ( )0.106

Table 4 cont… InterventionControlAdjusted odds ratioP value Environmental exposure to tobacco smoke Improved262 (61)222 (52)1.48 ( )<0.001 Not improved167 (39)209 (49)Reference- Smoking status at the end of study Never smoke241 (55)235 (54)Reference- Current smoker95 (22)129 (30)0.72 ( )0.045 Stopped smoking100 (23)72(17)1.36 ( )0.092 Stopped smoking during study period No93 (79)127(92)Reference- Yes25 (21)11 (8)3.10 ( )<0.004

Table 4 cont… InterventionControlAdjusted odds ratioP value Cumulative incidence of COPD Yes16 (4) 0.98 ( )0.964 No396 (96)358(96)Reference- Cumulative deaths from COPD Yes1 (2)6 (11)0.17 ( )0.120 No47 (98)47 (89)Reference- Cumulative deaths from all causes Yes6 (1)15(3)0.23 ( )<0.009 No430 (99)421 (97)Reference-

Discussion Study MRIFT- multiple risk factor intervention trial, US 6347 middle aged male smokers, 6-7 years of follow up Smoking Cessation has a beneficial effect on pulmonary function in heavy smokers Lung Health Study, US and Canada 5887 middle aged volunteers, Intervention was 10 week smoking cessation program at 14.5 years of follow up- Cause specific mortality reduced in special intervention group as compared to control

Conclusion This community based integrated intervention helped to prevent and control COPD through improved awareness of COPD, reduced risk factors for COPD, and a reduction of rate of decline in FEV1